One dose of a new monoclonal antibody prevented malaria for up to nine months in people who were exposed to the malaria parasite. The small, carefully monitored clinical trial is the first to demonstrate that a monoclonal antibody can prevent malaria in people.
from Top Health News -- ScienceDaily https://ift.tt/2VFkJQd
Post a Comment